MENOCOG Trial
What does creatine monohydrate supplementation do to cognition, mood and quality of life in postmenopausal women experiencing subjective cognitive decline? The MENOCOG Trial is a randomised controlled trial designed to investigate the feasibility, acceptability and safety of this intervention — and to generate early evidence on whether metabolic support of this kind has a meaningful role in the management of cognitive symptoms during the postmenopause.
The study sits at the intersection of neuroendocrinology, cognitive ageing and women's health — areas where the evidence base has historically been thin and where the need for rigorous, well-designed trials is acute. The MENOCOG Trial contributes to that evidence base.